TCRT Buybacks
17 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–17; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Alaunos Therapeutics, Inc. | 2023-12-31 | Reported repurchase cash | $0.00 |
| Alaunos Therapeutics, Inc. | 2022-12-31 | Reported repurchase cash | $0.00 |
| Alaunos Therapeutics, Inc. | 2021-12-31 | Reported repurchase cash | $0.00 |
| Alaunos Therapeutics, Inc. | 2019-12-31 | Reported repurchase cash | $283,000.00 |
| Alaunos Therapeutics, Inc. | 2018-12-31 | Reported repurchase cash | $347,000.00 |
| Alaunos Therapeutics, Inc. | 2018-03-31 | Reported repurchase cash | $731,000.00 |
| Alaunos Therapeutics, Inc. | 2016-12-31 | Reported repurchase cash | $0.00 |
| Alaunos Therapeutics, Inc. | 2015-12-31 | Reported repurchase cash | $0.00 |
| Alaunos Therapeutics, Inc. | 2015-03-31 | Reported repurchase cash | $246,000.00 |
| Alaunos Therapeutics, Inc. | 2014-12-31 | Reported repurchase cash | $412,000.00 |
| Alaunos Therapeutics, Inc. | 2014-03-31 | Reported repurchase cash | $132,000.00 |
| Alaunos Therapeutics, Inc. | 2013-12-31 | Reported repurchase cash | $248,000.00 |
| Alaunos Therapeutics, Inc. | 2013-03-31 | Reported repurchase cash | $246,000.00 |
| Alaunos Therapeutics, Inc. | 2012-12-31 | Reported repurchase cash | $450,000.00 |
| Alaunos Therapeutics, Inc. | 2011-12-31 | Reported repurchase cash | $196,000.00 |
| Alaunos Therapeutics, Inc. | 2011-03-31 | Reported repurchase cash | $78,000.00 |
| Alaunos Therapeutics, Inc. | 2010-12-31 | Reported repurchase cash | $239,000.00 |